152.1K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Lisa Wipperman Heine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 18 Feb 2025 | 2,640 | 16,093 (0%) | 0% | 27.3 | 72,072 | Common Stock |
Lisa Wipperman Heine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,640 | 0 | - | - | Stock Option (right to buy) | |
Lisa Wipperman Heine | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.09 per share. | 18 Feb 2025 | 2,115 | 13,978 (0%) | 0% | 34.1 | 72,100 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 14 Feb 2025 | 5,275 | 34,232 (0%) | 0% | 27.3 | 144,008 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,275 | 0 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.10 per share. | 14 Feb 2025 | 4,224 | 30,008 (0%) | 0% | 34.1 | 144,038 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 5,275 | 0 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 13 Feb 2025 | 5,275 | 44,399 (0%) | 0% | 27.3 | 144,008 | Common Stock |
David R. Dantzker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. | 13 Feb 2025 | 4,216 | 40,183 (0%) | 0% | 34.2 | 144,019 | Common Stock |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 24 Jan 2025 | 7,358 | 42,506 (0%) | 0% | 27.3 | 200,873 | Common Stock |
Susan E. Knight | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.15 per share. | 24 Jan 2025 | 5,266 | 37,240 (0%) | 0% | 38.2 | 200,898 | Common Stock |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 7,358 | 0 | - | - | Stock Option (right to buy) | |
Arens Timothy J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 1,265 | 67,299 (0%) | 0% | 39.9 | 50,486 | Common Stock |
John D. Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 152 | 8,155 (0%) | 0% | 39.9 | 6,066 | Common Stock |
Gordon Weber S. | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 668 | 21,040 (0%) | 0% | 39.9 | 26,660 | Common Stock |
Woodwick Sides Teri | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 946 | 34,703 (0%) | 0% | 39.9 | 37,755 | Common Stock |
Olson W. Charles | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 959 | 51,478 (0%) | 0% | 39.9 | 38,274 | Common Stock |
J. Stich Joseph | SVP of HR, President IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 1,034 | 61,631 (0%) | 0% | 39.9 | 41,267 | Common Stock |
R. Gary Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 4,248 | 192,056 (1%) | 0% | 39.9 | 169,538 | Common Stock |
Stich Joseph J. | SVP of HR, President IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,655 | 62,665 (0%) | 0% | 39.5 | 65,290 | Common Stock |
Maharaj Gary R. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 6,470 | 196,304 (1%) | 0% | 39.5 | 255,242 | Common Stock |
W. Charles Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,534 | 52,437 (0%) | 0% | 39.4 | 60,516 | Common Stock |
J. Arens Timothy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,786 | 68,564 (0%) | 0% | 39.5 | 70,458 | Common Stock |
D. John Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 387 | 8,307 (0%) | 0% | 39.4 | 15,267 | Common Stock |
Weber S. Gordon | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,030 | 21,708 (0%) | 0% | 39.5 | 40,634 | Common Stock |
Woodwick Sides Teri | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,312 | 35,649 (0%) | 0% | 39.4 | 51,758 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.44 per share. | 26 Nov 2024 | 7,009 | 70,350 (0%) | 0% | 39.4 | 276,453 | Common Stock |
Joseph J. Stich | SVP of HR, President IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2024 | 21,285 | 0 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | SVP of HR, President IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 21 Aug 2024 | 21,285 | 83,405 (0%) | 0% | 33.2 | 706,662 | Common Stock |
Joseph J. Stich | SVP of HR, President IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 21 Aug 2024 | 19,434 | 63,971 (0%) | 0% | 40.1 | 778,526 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2024 | 61,017 | 0 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 21 Aug 2024 | 50,569 | 202,582 (1%) | 0% | 40.1 | 2,025,794 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 21 Aug 2024 | 61,017 | 253,151 (1%) | 0% | 33.2 | 2,025,764 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 16 Aug 2024 | 16,727 | 53,971 (0%) | 0% | 40.1 | 670,084 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 18,447 | 0 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | SVP, Medical Device Coatings | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 16 Aug 2024 | 18,447 | 70,698 (0%) | 0% | 33.2 | 612,440 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 16 Aug 2024 | 16,729 | 77,359 (0%) | 0% | 40.1 | 670,164 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 16 Aug 2024 | 18,447 | 94,088 (0%) | 0% | 33.2 | 612,440 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 18,447 | 0 | - | - | Employee Stock Option (right to buy) | |
Lisa Heine Wipperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
Kalich B. Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 38,278 (0%) | 0% | 0 | Common Stock | |
Kalich B. Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
Knight E. Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,944 | 35,148 (0%) | 0% | 0 | Common Stock | |
Bedoya H. Jose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 28,957 (0%) | 0% | 0 | Common Stock | |
Dantzker David R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 39,124 (0%) | 0% | 0 | Common Stock | |
Jose Bedoya H. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 08 Feb 2024 | 3,932 | 30,108 (0%) | 0% | 23.9 | 94,171 | Common Stock |
Bedoya H. Jose | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 3,932 | 0 | - | - | Stock Option (right to buy) | |
E. Knight Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 4,155 | 4,155 | - | - | Stock Option (right to buy) | |
R. David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
Heine Lisa Wipperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 13,453 (0%) | 0% | 0 | Common Stock | |
Bedoya H. Jose | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.89 per share. | 08 Feb 2024 | 2,954 | 27,154 (0%) | 0% | 31.9 | 94,203 | Common Stock |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
Dantzker David R. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 19 Jan 2024 | 3,932 | 40,094 (0%) | 0% | 23.9 | 94,171 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2024 | 3,932 | 0 | - | - | Stock Option (right to buy) | |
Dantzker David R. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.97 per share. | 19 Jan 2024 | 2,773 | 37,321 (0%) | 0% | 34.0 | 94,199 | Common Stock |
Kalich B. Ronald | Director | Grant, award, or other acquisition of securities at price $ 36.35 per share. | 29 Dec 2023 | 491 | 36,475 (0%) | 0% | 36.4 | 17,848 | Common Stock |
B. Ronald Kalich | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.01 per share. | 27 Dec 2023 | 2,545 | 35,984 (0%) | 0% | 37.0 | 94,190 | Common Stock |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 3,932 | 0 | - | - | Stock Option (right to buy) | |
Ronald Kalich B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 27 Dec 2023 | 3,932 | 38,529 (0%) | 0% | 23.9 | 94,171 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 20,101 | 20,101 | - | - | Employee Stock Option (right to buy) | |
John Manders D. | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 3,160 | 3,160 | - | - | Employee Stock Option (right to buy) | |
Maharaj R. Gary | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 89,127 | 89,127 | - | - | Employee Stock Option (right to buy) | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 20,859 | 20,859 | - | - | Employee Stock Option (right to buy) | |
Arens Timothy J. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 26,548 | 26,548 | - | - | Employee Stock Option (right to buy) | |
J. Arens Timothy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 8,323 | 75,641 (0%) | 0% | 0 | Common Stock | |
Stich J. Joseph | SVP HR and IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 20,101 | 20,101 | - | - | Employee Stock Option (right to buy) | |
Teri Sides Woodwick | SVP, Vascular Interventions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 9,274 | 36,304 (0%) | 0% | 0 | Common Stock | |
Weber Gordon S. | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 6,539 | 22,065 (0%) | 0% | 0 | Common Stock | |
Gary Maharaj R. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 27,942 | 191,670 (1%) | 0% | 0 | Common Stock | |
Sides Teri Woodwick | SVP, Vascular Interventions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 29,582 | 29,582 | - | - | Employee Stock Option (right to buy) | |
Olson W. Charles | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 6,302 | 52,251 (0%) | 0% | 0 | Common Stock | |
Manders D. John | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,486 | 8,319 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | SVP HR and IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 6,302 | 61,796 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 3,703 | 163,728 (1%) | 0% | 32.8 | 121,532 | Common Stock |
Woodwick Teri Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 465 | 27,878 (0%) | 0% | 32.8 | 15,261 | Common Stock |
Woodwick Teri Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 436 | 28,343 (0%) | 0% | 32.8 | 14,310 | Common Stock |
Weber S. Gordon | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 565 | 15,526 (0%) | 0% | 32.8 | 18,543 | Common Stock |
J. Arens Timothy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 650 | 69,105 (0%) | 0% | 32.8 | 21,333 | Common Stock |
D. John Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 212 | 6,833 (0%) | 0% | 32.8 | 6,958 | Common Stock |
Woodwick Teri Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 848 | 27,030 (0%) | 0% | 32.8 | 27,831 | Common Stock |
Olson Charles W. | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 693 | 46,791 (0%) | 0% | 32.8 | 22,744 | Common Stock |
Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 68 | 7,220 (0%) | 0% | 32.8 | 2,232 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 650 | 47,484 (0%) | 0% | 32.8 | 21,333 | Common Stock |
Timothy Arens J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 1,094 | 67,318 (0%) | 0% | 32.8 | 35,905 | Common Stock |
Weber S. Gordon | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 436 | 16,556 (0%) | 0% | 32.8 | 14,310 | Common Stock |
Joseph Stich J. | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 747 | 56,402 (0%) | 0% | 32.8 | 24,517 | Common Stock |
Maharaj R. Gary | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 2,768 | 167,431 (1%) | 0% | 32.8 | 90,846 | Common Stock |
W. Charles Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 842 | 45,949 (0%) | 0% | 32.8 | 27,634 | Common Stock |
Stich J. Joseph | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 908 | 55,494 (0%) | 0% | 32.8 | 29,801 | Common Stock |
Timothy Arens J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 693 | 68,412 (0%) | 0% | 32.8 | 22,744 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 701 | 57,149 (0%) | 0% | 32.8 | 23,007 | Common Stock |
R. Maharaj Gary | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 2,639 | 170,199 (1%) | 0% | 32.8 | 86,612 | Common Stock |
Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 175 | 7,045 (0%) | 0% | 32.8 | 5,744 | Common Stock |
Gordon Weber S. | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 465 | 16,091 (0%) | 0% | 32.8 | 15,261 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 31.31 per share. | 30 Jun 2023 | 570 | 34,040 (0%) | 0% | 31.3 | 17,847 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 22.78 per share. | 31 Mar 2023 | 784 | 33,470 (0%) | 0% | 22.8 | 17,860 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 36,162 (0%) | 0% | 0 | Common Stock | |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 2,139 | 32,335 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 5,040 | 5,040 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 32,686 (0%) | 0% | 0 | Common Stock | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 26,176 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 11,650 (0%) | 0% | 0 | Common Stock | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 34.12 per share. | 31 Dec 2022 | 523 | 30,702 (0%) | 0% | 34.1 | 17,845 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 650 | 41,253 (0%) | 0% | 36.1 | 23,485 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 19,243 | 19,243 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 5,535 | 46,096 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 692 | 40,561 (0%) | 0% | 36.1 | 25,002 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 19,243 | 19,243 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 702 | 49,609 (0%) | 0% | 36.1 | 25,363 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 747 | 48,862 (0%) | 0% | 36.1 | 26,989 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 5,535 | 54,397 (0%) | 0% | 0 | Common Stock | |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 650 | 63,251 (0%) | 0% | 36.1 | 23,485 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 25,016 | 25,016 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 7,196 | 69,755 (0%) | 0% | 0 | Common Stock | |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 692 | 62,559 (0%) | 0% | 36.1 | 25,002 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 84,669 | 84,669 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 24,356 | 172,064 (1%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 2,768 | 147,708 (1%) | 0% | 36.1 | 100,008 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 2,639 | 150,476 (1%) | 0% | 36.1 | 95,347 | Common Stock |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 2,075 | 6,787 (0%) | 0% | 0 | Common Stock | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 4,810 | 4,810 | - | - | Employee Stock Option (right to buy) | |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 69 | 4,887 (0%) | 0% | 36.1 | 2,493 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 175 | 4,712 (0%) | 0% | 36.1 | 6,323 | Common Stock |
Teri Woodwick Sides | SVP, Vascular Interventions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 28,864 | 28,864 | - | - | Employee Stock Option (right to buy) | |
Teri Woodwick Sides | SVP, Vascular Interventions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 8,303 | 28,017 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 465 | 19,714 (0%) | 0% | 36.1 | 16,800 | Common Stock |
Teri Woodwick Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 437 | 20,179 (0%) | 0% | 36.1 | 15,789 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 465 | 10,240 (0%) | 0% | 36.1 | 16,800 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 19,243 | 19,243 | - | - | Employee Stock Option (right to buy) | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 5,535 | 16,077 (0%) | 0% | 0 | Common Stock | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 437 | 10,705 (0%) | 0% | 36.1 | 15,789 | Common Stock |
Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 28 Nov 2022 | 4,366 | 24,192 (0%) | 0% | 34.9 | 152,321 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 28 Nov 2022 | 4,366 | 28,558 (0%) | 0% | 20.2 | 88,106 | Common Stock |
Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 471 | 41,903 (0%) | 0% | 36.0 | 16,965 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 586 | 50,311 (0%) | 0% | 36.0 | 21,108 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 543 | 63,901 (0%) | 0% | 36.0 | 19,559 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 2,172 | 153,115 (1%) | 0% | 36.0 | 78,235 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 61 | 4,956 (0%) | 0% | 36.0 | 2,197 | Common Stock |
Teri Woodwick Sides | SVP, Vascular Interventions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 365 | 20,616 (0%) | 0% | 36.0 | 13,147 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 14 Nov 2022 | 4,366 | 36,951 (0%) | 0% | 20.2 | 88,106 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 14 Nov 2022 | 2,773 | 34,178 (0%) | 0% | 33.0 | 91,507 | Common Stock |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 11 Nov 2022 | 4,366 | 32,912 (0%) | 0% | 20.2 | 88,106 | Common Stock |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 11 Nov 2022 | 2,733 | 30,179 (0%) | 0% | 33.5 | 91,511 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 30.40 per share. | 30 Sep 2022 | 587 | 28,546 (0%) | 0% | 30.4 | 17,845 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 19 Jul 2022 | 15,386 | 50,596 (0%) | 0% | 36.7 | 565,128 | Common Stock |
Joseph J. Stich | SVP HR and IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2022 | 19,927 | 0 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | SVP HR and IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 19 Jul 2022 | 19,927 | 65,766 (0%) | 0% | 20.3 | 403,522 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 37.23 per share. | 30 Jun 2022 | 480 | 27,959 (0%) | 0% | 37.2 | 17,870 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.91 per share. | 13 May 2022 | 151 | 64,444 (0%) | 0% | 35.9 | 5,422 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.33 per share. | 12 May 2022 | 339 | 11,142 (0%) | 0% | 34.3 | 11,638 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 45.55 per share. | 01 Apr 2022 | 100 | 155,041 (1%) | 0% | 45.6 | 4,555 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 44.97 per share. | 01 Apr 2022 | 3,900 | 155,141 (1%) | 0% | 45.0 | 175,399 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 45.33 per share. | 31 Mar 2022 | 394 | 27,479 (0%) | 0% | 45.3 | 17,860 | Common Stock |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 28 Feb 2022 | 4,366 | 34,562 (0%) | 0% | 20.2 | 88,106 | Common Stock |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
Susan E. Knight | Director | Sale of securities on an exchange or to another person at price $ 44.97 per share. | 28 Feb 2022 | 4,366 | 30,196 (0%) | 0% | 45.0 | 196,332 | Common Stock |
Nusrath Sultana | VP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.67 per share. | 12 Feb 2022 | 762 | 6,530 (0%) | 0% | 41.7 | 31,753 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 32,585 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,482 | 30,196 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,834 | 3,834 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 27,085 (0%) | 0% | 0 | Common Stock | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 24,192 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 9,666 (0%) | 0% | 0 | Common Stock | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 04 Jan 2022 | 2,500 | 45,839 (0%) | 0% | 50 | 125,000 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 650 | 37,822 (0%) | 0% | 43.9 | 28,555 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 42,374 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 30 Nov 2021 | 5,576 | 28,393 (0%) | 0% | 21.3 | 118,825 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 5,576 | 0 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 30 Nov 2021 | 5,576 | 22,817 (0%) | 0% | 44.0 | 245,350 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | SVP, HR and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 48,339 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 701 | 43,787 (0%) | 0% | 43.9 | 30,795 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 650 | 60,043 (0%) | 0% | 43.9 | 28,555 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 64,595 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 73,349 | 73,349 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,210 | 158,733 (1%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 2,639 | 140,523 (1%) | 0% | 43.9 | 115,931 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 68 | 3,033 (0%) | 0% | 43.9 | 2,987 | Common Stock |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,584 | 4,584 | - | - | Employee Stock Option (right to buy) | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 1,707 | 4,740 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 436 | 15,942 (0%) | 0% | 43.9 | 19,153 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 20,494 (0%) | 0% | 0 | Common Stock | |
Nusrath Sultana | VP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 431 | 6,382 (0%) | 0% | 43.9 | 18,934 | Common Stock |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 910 | 7,292 (0%) | 0% | 0 | Common Stock | |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 3,667 | 3,667 | - | - | Employee Stock Option (right to buy) | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 436 | 6,713 (0%) | 0% | 43.9 | 19,153 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 11,265 (0%) | 0% | 0 | Common Stock | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 471 | 38,821 (0%) | 0% | 47.8 | 22,537 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 349 | 38,472 (0%) | 0% | 45.8 | 15,974 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 586 | 44,923 (0%) | 0% | 47.8 | 28,040 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 435 | 44,488 (0%) | 0% | 45.8 | 19,910 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 544 | 61,042 (0%) | 0% | 47.8 | 26,030 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 349 | 60,693 (0%) | 0% | 45.8 | 15,974 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 2,172 | 144,639 (1%) | 0% | 47.8 | 103,930 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 1,477 | 143,162 (1%) | 0% | 45.8 | 67,602 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 61 | 3,146 (0%) | 0% | 47.9 | 2,919 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.78 per share. | 25 Nov 2021 | 45 | 3,101 (0%) | 0% | 45.8 | 2,060 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 948 | 16,649 (0%) | 0% | 47.9 | 45,362 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 271 | 16,378 (0%) | 0% | 45.8 | 12,404 | Common Stock |
David R. Dantzker | Director | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 24 Nov 2021 | 3,475 | 30,821 (0%) | 0% | 47.0 | 163,360 | Common Stock |
David R. Dantzker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.56 per share. | 03 Nov 2021 | 2,101 | 34,296 (0%) | 0% | 56.6 | 118,833 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 5,576 | 0 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 03 Nov 2021 | 5,576 | 36,397 (0%) | 0% | 21.3 | 118,825 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.24 per share. | 01 Nov 2021 | 200 | 146,811 (1%) | 0% | 55.2 | 11,049 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.63 per share. | 01 Nov 2021 | 5,800 | 147,011 (1%) | 0% | 54.6 | 316,855 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.53 per share. | 01 Oct 2021 | 500 | 152,811 (1%) | 0% | 56.5 | 28,267 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 01 Oct 2021 | 5,500 | 153,311 (1%) | 0% | 56.0 | 307,831 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 55.60 per share. | 30 Sep 2021 | 337 | 30,821 (0%) | 0% | 55.6 | 18,737 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 55.60 per share. | 30 Sep 2021 | 321 | 25,339 (0%) | 0% | 55.6 | 17,848 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.34 per share. | 15 Sep 2021 | 4,970 | 158,811 (1%) | 0% | 57.3 | 284,976 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.68 per share. | 15 Sep 2021 | 1,030 | 163,781 (1%) | 0% | 56.7 | 58,383 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 31 Aug 2021 | 1,292 | 39,292 (0%) | 0% | 59.8 | 77,197 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.07 per share. | 31 Aug 2021 | 8,410 | 61,586 (0%) | 0% | 60.1 | 505,189 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2021 | 12,498 | 0 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 31 Aug 2021 | 12,498 | 69,996 (0%) | 0% | 23.9 | 299,327 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. | 24 Aug 2021 | 14,276 | 56,552 (0%) | 0% | 21.0 | 300,224 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2021 | 14,276 | 0 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | SVP, HR and GM, IVD | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2021 | 1,500 | 45,314 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.14 per share. | 24 Aug 2021 | 9,738 | 46,814 (0%) | 0% | 56.1 | 546,691 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 54.40 per share. | 19 Aug 2021 | 2,500 | 42,276 (0%) | 0% | 54.4 | 136,002 | Common Stock |
John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 54.25 per share. | 11 Aug 2021 | 53 | 3,108 (0%) | 0% | 54.2 | 2,875 | Common Stock |
John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 11 Aug 2021 | 2,608 | 5,716 (0%) | 0% | 23.0 | 59,854 | Common Stock |
John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 53.33 per share. | 11 Aug 2021 | 2,555 | 3,161 (0%) | 0% | 53.3 | 136,261 | Common Stock |
John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 2,608 | 0 | - | - | Employee Stock Option (right to buy) | |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 4,430 | 0 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.78 per share. | 06 Aug 2021 | 1,663 | 25,018 (0%) | 0% | 56.8 | 94,425 | Common Stock |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 06 Aug 2021 | 4,430 | 26,681 (0%) | 0% | 21.3 | 94,403 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.45 per share. | 17 Jul 2021 | 31 | 3,108 (0%) | 0% | 53.5 | 1,657 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 54.25 per share. | 30 Jun 2021 | 345 | 30,484 (0%) | 0% | 54.2 | 18,716 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 54.25 per share. | 30 Jun 2021 | 329 | 22,251 (0%) | 0% | 54.2 | 17,848 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Gift of securities by or to the insider at price $ 0.00 per share. | 20 May 2021 | 1,000 | 44,776 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 53.80 per share. | 20 May 2021 | 2,500 | 45,776 (0%) | 0% | 53.8 | 134,506 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.24 per share. | 13 May 2021 | 134 | 57,498 (0%) | 0% | 53.2 | 7,134 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.99 per share. | 12 May 2021 | 292 | 6,955 (0%) | 0% | 53.0 | 15,473 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 28 Apr 2021 | 1,508 | 40,584 (0%) | 0% | 59.8 | 90,103 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 16 Apr 2021 | 648 | 42,092 (0%) | 0% | 59.8 | 38,718 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Sale of securities on an exchange or to another person at price $ 56.75 per share. | 31 Mar 2021 | 4,759 | 42,740 (0%) | 0% | 56.7 | 270,073 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 56.07 per share. | 31 Mar 2021 | 334 | 30,139 (0%) | 0% | 56.1 | 18,727 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 56.07 per share. | 31 Mar 2021 | 318 | 21,922 (0%) | 0% | 56.1 | 17,830 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 52.67 per share. | 01 Mar 2021 | 999 | 164,713 (1%) | 0% | 52.7 | 52,620 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 51.86 per share. | 01 Mar 2021 | 3,001 | 165,712 (1%) | 0% | 51.9 | 155,639 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 26 Feb 2021 | 9,964 | 56,638 (0%) | 0% | 20.3 | 201,771 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.15 per share. | 26 Feb 2021 | 9,139 | 47,499 (0%) | 0% | 52.2 | 476,599 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. | 26 Feb 2021 | 3,569 | 46,674 (0%) | 0% | 21.0 | 75,056 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 9,964 | 0 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 3,569 | 0 | - | - | Employee Stock Option (right to buy) | |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 5,576 | 0 | - | - | Stock Option (right to buy) | |
Susan E. Knight | Director | Sale of securities on an exchange or to another person at price $ 52.36 per share. | 26 Feb 2021 | 5,576 | 28,714 (0%) | 0% | 52.4 | 291,955 | Common Stock |
Susan E. Knight | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 26 Feb 2021 | 5,576 | 34,290 (0%) | 0% | 21.3 | 118,825 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 2,614 | 0 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 8,359 | 0 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 24 Feb 2021 | 7,444 | 57,632 (0%) | 0% | 51.7 | 384,855 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 24 Feb 2021 | 8,359 | 65,076 (0%) | 0% | 20.3 | 169,270 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. | 24 Feb 2021 | 2,614 | 56,717 (0%) | 0% | 21.0 | 54,972 | Common Stock |
Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 50.68 per share. | 23 Feb 2021 | 1,497 | 22,817 (0%) | 0% | 50.7 | 75,868 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 16 Feb 2021 | 484 | 48,062 (0%) | 0% | 52.5 | 25,414 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 51.50 per share. | 16 Feb 2021 | 2,016 | 48,546 (0%) | 0% | 51.5 | 103,823 | Common Stock |
Nusrath Sultana | VP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.17 per share. | 12 Feb 2021 | 449 | 6,566 (0%) | 0% | 53.2 | 23,873 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,964 | 2,964 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,067 | 29,805 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 3,196 | 3,196 | - | - | Stock Option (right to buy) | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,151 | 28,714 (0%) | 0% | 0 | Common Stock | |
Ronald B. Kalich | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.17 per share. | 11 Feb 2021 | 1,900 | 21,604 (0%) | 0% | 53.2 | 101,023 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,964 | 2,964 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,098 | 0 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,067 | 19,406 (0%) | 0% | 0 | Common Stock | |
Ronald B. Kalich | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 11 Feb 2021 | 4,098 | 23,504 (0%) | 0% | 26.5 | 108,433 | Common Stock |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,067 | 24,314 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,964 | 2,964 | - | - | Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. | 11 Feb 2021 | 10,311 | 152,453 (1%) | 0% | 21.0 | 216,840 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 11 Feb 2021 | 44,779 | 224,406 (1%) | 0% | 23.9 | 1,072,457 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.86 per share. | 11 Feb 2021 | 56,152 | 168,254 (1%) | 0% | 53.9 | 3,024,347 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 10,311 | 0 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 27,174 | 0 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 44,779 | 0 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 11 Feb 2021 | 27,174 | 179,627 (1%) | 0% | 20.3 | 550,274 | Common Stock |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,964 | 2,964 | - | - | Stock Option (right to buy) | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,067 | 8,291 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 44.77 per share. | 01 Feb 2021 | 2,843 | 142,299 (1%) | 0% | 44.8 | 127,273 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 45.54 per share. | 01 Feb 2021 | 157 | 142,142 (1%) | 0% | 45.5 | 7,150 | Common Stock |
Joseph J. Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 05 Jan 2021 | 2,500 | 50,562 (0%) | 0% | 45 | 112,500 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 43.96 per share. | 04 Jan 2021 | 2,000 | 145,142 (1%) | 0% | 44.0 | 87,926 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,883 | 17,883 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 4,273 | 43,105 (0%) | 0% | 0 | Common Stock | |
Joseph Stich | SVP, HR and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 4,273 | 53,062 (0%) | 0% | 0 | Common Stock | |
Joseph Stich | SVP, HR and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,883 | 17,883 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 4,273 | 54,103 (0%) | 0% | 0 | Common Stock | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,883 | 17,883 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 74,515 | 74,515 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,361 | 147,142 (1%) | 0% | 0 | Common Stock | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 1,862 | 1,862 | - | - | Employee Stock Option (right to buy) | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 667 | 3,033 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 4,273 | 16,994 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,883 | 17,883 | - | - | Employee Stock Option (right to buy) | |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 15,648 | 15,648 | - | - | Employee Stock Option (right to buy) | |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 3,739 | 7,015 (0%) | 0% | 0 | Common Stock | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 17,883 | 17,883 | - | - | Employee Stock Option (right to buy) | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 4,273 | 7,033 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 349 | 39,428 (0%) | 0% | 38.4 | 13,388 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 596 | 38,832 (0%) | 0% | 38.4 | 22,863 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 471 | 39,777 (0%) | 0% | 38.9 | 18,336 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 586 | 49,964 (0%) | 0% | 38.9 | 22,813 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 741 | 48,789 (0%) | 0% | 38.4 | 28,425 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 434 | 49,530 (0%) | 0% | 38.4 | 16,648 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 543 | 50,775 (0%) | 0% | 38.9 | 21,139 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 349 | 50,426 (0%) | 0% | 38.4 | 13,388 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 596 | 49,830 (0%) | 0% | 38.4 | 22,863 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 1,969 | 129,781 (0%) | 0% | 38.4 | 75,531 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 1,477 | 131,750 (0%) | 0% | 38.4 | 56,658 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 2,172 | 133,227 (0%) | 0% | 38.9 | 84,556 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 61 | 2,411 (0%) | 0% | 38.9 | 2,375 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 45 | 2,366 (0%) | 0% | 38.4 | 1,726 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 365 | 14,432 (0%) | 0% | 38.9 | 14,209 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 1,711 | 12,721 (0%) | 0% | 38.4 | 65,634 | Common Stock |
Jose H. Bedoya | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.86 per share. | 17 Nov 2020 | 2,078 | 23,247 (0%) | 0% | 38.9 | 80,751 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 3,575 | 0 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. | 17 Nov 2020 | 3,575 | 25,325 (0%) | 0% | 22.6 | 80,724 | Common Stock |
David Dantzker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.54 per share. | 10 Nov 2020 | 2,095 | 28,376 (0%) | 0% | 38.5 | 80,741 | Common Stock |
David Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. | 10 Nov 2020 | 3,575 | 30,471 (0%) | 0% | 22.6 | 80,724 | Common Stock |
David Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 3,575 | 0 | - | - | Stock Option (right to buy) | |
David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 38.91 per share. | 30 Sep 2020 | 417 | 26,896 (0%) | 0% | 38.9 | 16,225 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 38.91 per share. | 30 Sep 2020 | 459 | 17,929 (0%) | 0% | 38.9 | 17,860 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Sep 2020 | 1,300 | 50,550 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 45.07 per share. | 01 Sep 2020 | 3,000 | 135,399 (0%) | 0% | 45.1 | 135,206 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 46.71 per share. | 19 Aug 2020 | 2,500 | 51,570 (0%) | 0% | 46.7 | 116,781 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 47.44 per share. | 03 Aug 2020 | 3,000 | 138,142 (1%) | 0% | 47.4 | 142,334 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2020 | 12,612 | 0 | - | - | Employee Stock Option (right to buy) | |
Joseph Stich | SVP, HR and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.97 per share. | 22 Jul 2020 | 9,418 | 54,070 (0%) | 0% | 45.0 | 423,527 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. | 22 Jul 2020 | 12,612 | 63,488 (0%) | 0% | 22.6 | 284,779 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.34 per share. | 17 Jul 2020 | 95 | 51,318 (0%) | 0% | 45.3 | 4,307 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.35 per share. | 17 Jul 2020 | 31 | 2,339 (0%) | 0% | 45.4 | 1,406 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 43.02 per share. | 01 Jul 2020 | 2,000 | 141,142 (1%) | 0% | 43.0 | 86,037 | Common Stock |
David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 43.24 per share. | 30 Jun 2020 | 375 | 26,479 (0%) | 0% | 43.2 | 16,215 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 43.24 per share. | 30 Jun 2020 | 413 | 17,470 (0%) | 0% | 43.2 | 17,858 | Common Stock |
Joseph Stich | SVP, HR and GM, IVD | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jun 2020 | 623 | 50,876 (0%) | 0% | 0 | Common Stock | |
Joseph Stich | SVP, HR and GM, IVD | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 09 Jun 2020 | 2,500 | 51,499 (0%) | 0% | 45 | 112,500 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.18 per share. | 13 May 2020 | 149 | 51,413 (0%) | 0% | 35.2 | 5,242 | Common Stock |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2020 | 11,538 | 11,538 | - | - | Employee Stock Option (right to buy) | |
Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2020 | 2,760 | 2,760 (0%) | 0% | 0 | Common Stock | |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.02 per share. | 03 May 2020 | 131 | 2,370 (0%) | 0% | 38.0 | 4,981 | Common Stock |
David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 33.32 per share. | 31 Mar 2020 | 487 | 26,104 (0%) | 0% | 33.3 | 16,227 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 33.32 per share. | 31 Mar 2020 | 536 | 17,057 (0%) | 0% | 33.3 | 17,860 | Common Stock |
Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 37.51 per share. | 20 Feb 2020 | 1,821 | 21,750 (0%) | 0% | 37.5 | 68,314 | Common Stock |
David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,218 | 4,218 | - | - | Stock Option (right to buy) | |
David Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,452 | 25,617 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,566 | 27,563 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,548 | 4,548 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,218 | 4,218 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,452 | 16,521 (0%) | 0% | 0 | Common Stock | |
Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,218 | 4,218 | - | - | Stock Option (right to buy) | |
Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,452 | 9,210 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,218 | 4,218 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,452 | 23,571 (0%) | 0% | 0 | Common Stock | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 1,452 | 7,224 (0%) | 0% | 0 | Common Stock | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,218 | 4,218 | - | - | Stock Option (right to buy) | |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 3,276 | 3,276 (0%) | 0% | 0 | Common Stock | |
Nusrath Sultana | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 14,264 | 14,264 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 02 Jan 2020 | 702 | 142,885 (1%) | 0% | 41.1 | 28,841 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 41.43 per share. | 31 Dec 2019 | 392 | 24,165 (0%) | 0% | 41.4 | 16,241 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 41.43 per share. | 31 Dec 2019 | 431 | 15,069 (0%) | 0% | 41.4 | 17,856 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 40.74 per share. | 02 Dec 2019 | 730 | 143,587 (1%) | 0% | 40.7 | 29,743 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 40.33 per share. | 02 Dec 2019 | 4,270 | 144,317 (1%) | 0% | 40.3 | 172,210 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 413 | 35,311 (0%) | 0% | 41.0 | 16,950 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 687 | 35,724 (0%) | 0% | 40.9 | 28,091 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 403 | 36,411 (0%) | 0% | 40.9 | 16,479 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 596 | 40,661 (0%) | 0% | 40.9 | 24,370 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 349 | 41,257 (0%) | 0% | 40.9 | 14,271 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 413 | 40,248 (0%) | 0% | 41.0 | 16,950 | Common Stock |
Gregg Sutton | VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 413 | 25,263 (0%) | 0% | 41.0 | 16,950 | Common Stock |
Gregg Sutton | VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 687 | 25,676 (0%) | 0% | 40.9 | 28,091 | Common Stock |
Gregg Sutton | VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 403 | 26,363 (0%) | 0% | 40.9 | 16,479 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 435 | 54,948 (0%) | 0% | 40.9 | 17,787 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 445 | 53,762 (0%) | 0% | 41.0 | 18,263 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 741 | 54,207 (0%) | 0% | 40.9 | 30,299 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 596 | 51,975 (0%) | 0% | 40.9 | 24,370 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 413 | 51,562 (0%) | 0% | 41.0 | 16,950 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 349 | 52,571 (0%) | 0% | 40.9 | 14,271 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. | 27 Nov 2019 | 1,079 | 148,587 (1%) | 0% | 41.0 | 44,282 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 1,969 | 149,666 (1%) | 0% | 40.9 | 80,512 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 1,477 | 151,635 (1%) | 0% | 40.9 | 60,395 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 45 | 2,404 (0%) | 0% | 40.9 | 1,840 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 271 | 14,194 (0%) | 0% | 40.9 | 11,081 | Common Stock |
Teri Woodwick Sides | Senior VP and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. | 27 Nov 2019 | 721 | 14,465 (0%) | 0% | 40.9 | 29,482 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 3,581 | 36,814 (0%) | 0% | 42 | 150,402 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 40,395 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 13,579 | 13,579 | - | - | Employee Stock Option (right to buy) | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,095 | 41,606 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 42,092 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 3,581 | 38,511 (0%) | 0% | 42 | 150,402 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2019 | 3,537 | 0 | - | - | Stock Option (right to buy) | |
David R. Dantzker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 1,716 | 23,773 (0%) | 0% | 42 | 72,072 | Common Stock |
David R. Dantzker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.37 per share. | 25 Nov 2019 | 3,537 | 25,489 (0%) | 0% | 20.4 | 72,049 | Common Stock |
Gregg Sutton | VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 1,904 | 23,195 (0%) | 0% | 0 | Common Stock | |
Gregg Sutton | VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 15,668 | 15,668 | - | - | Employee Stock Option (right to buy) | |
Gregg Sutton | VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 8,356 | 8,356 | - | - | Employee Stock Option (right to buy) | |
Gregg Sutton | VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,571 | 26,766 (0%) | 0% | 0 | Common Stock | |
Gregg Sutton | VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 3,581 | 21,291 (0%) | 0% | 42 | 150,402 | Common Stock |
Gregg Sutton | VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 24,872 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.37 per share. | 25 Nov 2019 | 3,537 | 23,835 (0%) | 0% | 20.4 | 72,049 | Common Stock |
Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2019 | 3,537 | 0 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 1,716 | 22,119 (0%) | 0% | 42 | 72,072 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 56,676 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | VP and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 15,668 | 15,668 | - | - | Employee Stock Option (right to buy) | |
Joseph J. Stich | VP and GM, IVD | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2019 | 1,000 | 55,383 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | VP and GM, IVD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,571 | 56,383 (0%) | 0% | 0 | Common Stock | |
Joseph J. Stich | VP and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 3,864 | 52,812 (0%) | 0% | 42 | 162,288 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,571 | 52,920 (0%) | 0% | 0 | Common Stock | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 15,668 | 15,668 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 3,581 | 49,349 (0%) | 0% | 42 | 150,402 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 52,930 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 14,285 | 153,112 (1%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 62,674 | 62,674 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 20,541 | 148,194 (1%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. | 25 Nov 2019 | 9,367 | 138,827 (1%) | 0% | 42 | 393,414 | Common Stock |
Thomas A. Greaney | COO of Medical Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,571 | 30,013 (0%) | 0% | 0 | Common Stock | |
Thomas A. Greaney | COO of Medical Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 7,852 | 26,442 (0%) | 0% | 0 | Common Stock | |
Thomas A. Greaney | COO of Medical Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 15,668 | 15,668 | - | - | Employee Stock Option (right to buy) | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 595 | 2,449 (0%) | 0% | 0 | Common Stock | |
John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 1,740 | 1,740 | - | - | Employee Stock Option (right to buy) | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 3,571 | 15,186 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 1,904 | 11,615 (0%) | 0% | 0 | Common Stock | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 15,668 | 15,668 | - | - | Employee Stock Option (right to buy) | |
Teri Woodwick Sides | Senior VP and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2019 | 8,356 | 8,356 | - | - | Employee Stock Option (right to buy) | |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 41.29 per share. | 01 Nov 2019 | 500 | 127,653 (0%) | 0% | 41.3 | 20,644 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 40.52 per share. | 01 Nov 2019 | 4,500 | 128,153 (0%) | 0% | 40.5 | 182,318 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.14 per share. | 01 Oct 2019 | 300 | 132,653 (0%) | 0% | 46.1 | 13,843 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 01 Oct 2019 | 4,700 | 132,953 (0%) | 0% | 45.5 | 213,655 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 45.74 per share. | 30 Sep 2019 | 306 | 21,952 (0%) | 0% | 45.7 | 13,996 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 45.74 per share. | 30 Sep 2019 | 333 | 14,638 (0%) | 0% | 45.7 | 15,231 | Common Stock |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.00 per share. | 26 Sep 2019 | 1,109 | 34,240 (0%) | 0% | 45 | 49,905 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.00 per share. | 26 Sep 2019 | 924 | 45,078 (0%) | 0% | 45 | 41,580 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 46.32 per share. | 23 Sep 2019 | 2,000 | 48,824 (0%) | 0% | 46.3 | 92,631 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 45.95 per share. | 03 Sep 2019 | 5,000 | 137,653 (1%) | 0% | 46.0 | 229,765 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 01 Aug 2019 | 2,000 | 50,637 (0%) | 0% | 47 | 94,000 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.78 per share. | 01 Aug 2019 | 2,770 | 142,205 (1%) | 0% | 46.8 | 129,585 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.15 per share. | 01 Aug 2019 | 2,230 | 144,975 (1%) | 0% | 46.1 | 102,913 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.50 per share. | 17 Jul 2019 | 108 | 46,002 (0%) | 0% | 39.5 | 4,266 | Common Stock |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.52 per share. | 17 Jul 2019 | 31 | 1,778 (0%) | 0% | 39.5 | 1,225 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.97 per share. | 01 Jul 2019 | 3,030 | 147,205 (1%) | 0% | 43.0 | 130,211 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.18 per share. | 01 Jul 2019 | 1,970 | 150,235 (1%) | 0% | 42.2 | 83,087 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 43.17 per share. | 28 Jun 2019 | 324 | 21,646 (0%) | 0% | 43.2 | 13,987 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 43.17 per share. | 28 Jun 2019 | 353 | 14,305 (0%) | 0% | 43.2 | 15,239 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 40.95 per share. | 03 Jun 2019 | 5,000 | 152,205 (1%) | 0% | 40.9 | 204,740 | Common Stock |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2019 | 2,615 | 2,615 | - | - | Employee Stock Option (right to buy) | |
Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2019 | 874 | 46,110 (0%) | 0% | 0 | Common Stock | |
John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.33 per share. | 03 May 2019 | 131 | 1,809 (0%) | 0% | 45.3 | 5,938 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.68 per share. | 01 May 2019 | 5,000 | 157,205 (1%) | 0% | 42.7 | 213,390 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 01 Apr 2019 | 5,000 | 162,205 (1%) | 0% | 42.9 | 214,498 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 43.48 per share. | 29 Mar 2019 | 321 | 21,322 (0%) | 0% | 43.5 | 13,957 | Common Stock |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 43.48 per share. | 29 Mar 2019 | 350 | 13,952 (0%) | 0% | 43.5 | 15,218 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 29 Mar 2019 | 1,900 | 52,637 (0%) | 0% | 45 | 85,500 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 45.54 per share. | 22 Mar 2019 | 100 | 54,537 (0%) | 0% | 45.5 | 4,554 | Common Stock |
Lisa Wipperman Heine | Director | Sale of securities on an exchange or to another person at price $ 57.38 per share. | 25 Feb 2019 | 2,569 | 5,772 (0%) | 0% | 57.4 | 147,408 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 55.42 per share. | 15 Feb 2019 | 1,103 | 54,791 (0%) | 0% | 55.4 | 61,125 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 56.30 per share. | 15 Feb 2019 | 297 | 54,494 (0%) | 0% | 56.3 | 16,720 | Common Stock |
Joseph J. Stich | VP and GM, IVD | Sale of securities on an exchange or to another person at price $ 54.44 per share. | 15 Feb 2019 | 600 | 55,894 (0%) | 0% | 54.4 | 32,662 | Common Stock |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 859 | 21,001 (0%) | 0% | 0 | Common Stock | |
David R. Dantzker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 2,605 | 2,605 | - | - | Stock Option (right to buy) | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 1,199 | 25,997 (0%) | 0% | 0 | Common Stock | |
Susan E. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 3,634 | 3,634 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 2,605 | 2,605 | - | - | Stock Option (right to buy) | |
Ronald B. Kalich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 859 | 13,602 (0%) | 0% | 0 | Common Stock | |
Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 2,605 | 2,605 | - | - | Stock Option (right to buy) | |
Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 859 | 7,758 (0%) | 0% | 0 | Common Stock | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 2,605 | 2,605 | - | - | Stock Option (right to buy) | |
Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 859 | 20,298 (0%) | 0% | 0 | Common Stock | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 2,605 | 2,605 | - | - | Stock Option (right to buy) | |
Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 859 | 8,341 (0%) | 0% | 0 | Common Stock | |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.20 per share. | 02 Jan 2019 | 4,900 | 174,967 (1%) | 0% | 46.2 | 226,402 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.83 per share. | 02 Jan 2019 | 100 | 174,867 (1%) | 0% | 46.8 | 4,683 | Common Stock |
David Dantzker | None | Grant, award, or other acquisition of securities at price $ 47.26 per share. | 31 Dec 2018 | 296 | 20,142 (0%) | 0% | 47.3 | 13,989 | Common Stock |
Ronald B. Kalich | None | Grant, award, or other acquisition of securities at price $ 47.26 per share. | 31 Dec 2018 | 322 | 12,743 (0%) | 0% | 47.3 | 15,218 | Common Stock |
Shawn T. McCormick | None | Grant, award, or other acquisition of securities at price $ 47.26 per share. | 31 Dec 2018 | 133 | 6,899 (0%) | 0% | 47.3 | 6,286 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 413 | 32,873 (0%) | 0% | 60.6 | 25,024 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Nov 2018 | 330 | 32,543 (0%) | 0% | 0 | Common Stock | |
Charles W. Olson | Senior VP of Bus Dev, Med Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 413 | 35,349 (0%) | 0% | 60.6 | 25,024 | Common Stock |
Gregg Sutton | VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 413 | 16,403 (0%) | 0% | 60.6 | 25,024 | Common Stock |
Joseph Stich | VP and GM, IVD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 413 | 56,494 (0%) | 0% | 60.6 | 25,024 | Common Stock |
Timothy J. Arens | Interim VP, Finance, and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 413 | 45,236 (0%) | 0% | 60.6 | 25,024 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 60.38 per share. | 30 Nov 2018 | 896 | 179,867 (1%) | 0% | 60.4 | 54,099 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 59.57 per share. | 30 Nov 2018 | 1,557 | 180,763 (1%) | 0% | 59.6 | 92,754 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.85 per share. | 30 Nov 2018 | 2,547 | 182,320 (1%) | 0% | 58.9 | 149,892 | Common Stock |
Gary R. Maharaj | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.59 per share. | 30 Nov 2018 | 1,079 | 184,867 (1%) | 0% | 60.6 | 65,377 | Common Stock |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2018 | 8,711 | 37,946 (0%) | 0% | 0 | Common Stock | |
Bryan K. Phillips | SVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2018 | 2,648 | 29,235 (0%) | 0% | 0 | Common Stock |